Active	Status	Sponsor type	Region	Phase	Filter
3 Active 1 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
izastobart (HIB210) / Biogen
NCT05928585: A Study of Safety and Drug Levels of HIB210 in Healthy Volunteers	Completed	1	30	US	HIB210, Placebo	HI-Bio	Immune System Diseases, Autoimmunity	06/24	06/24
NCT04947033: A Study Evaluating TJ210001 in the Treatment of Subjects With Advanced Solid Tumors	Recruiting	1	25	RoW	TJ210001 Injection	I-Mab Biopharma Co. Ltd.	Advanced Solid Tumor	12/24	12/25
NCT05511350: Expanded Access Protocol for Subjects With Relapsed or Refractory Advanced Solid Tumors Receiving TJ210001	No Longer Available	N/A		NA	TJ210001	I-Mab Biopharma Co. Ltd.	Solid Tumor Metastatic Cancer Advanced Cancer